Skip to main content

Major Depressive Disorder

June 15, 2020
Adjunctive esketamine appears effective for patients with major depressive disorder (MDD) who are treatment-resistant or suicidal, a meta-analysis published in The Journal of Clinical Psychiatry concluded.
June 15, 2020
A novel vasopressin 1B (V1B) receptor antagonist eased depressive symptoms when used as an adjunctive treatment in patients with major depressive disorder (MDD) in a small phase 2 study in the Journal of Psychiatric Research.
May 04, 2020
People with low mood and a history of depression tend not to use mood-modifying activities to stabilize mood, according to research published online in JAMA Psychiatry.
April 20, 2020
Depression is “vastly underdiagnosed” in people with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), states a literature review published online in the Harvard Review of Psychiatry.
April 13, 2020
The protein GPR56 may provide an easy-to-measure biomarker of a patient’s response to antidepressants as well as a novel drug target for the treatment of major depressive disorder, according to a published study.
March 26, 2020
After a Breakthrough Therapy guidance meeting with the US Food & Drug Administration (FDA), Sage Therapeutics announced plans to launch 3 additional studies of its investigational drug zuranolone.
February 24, 2020
    AXS-05, an investigational modulated-delivery tablet, significantly improved symptoms of depression
February 14, 2020
Researchers have developed a machine learning algorithm that uses electroencephalogram (EEG) data to predict whether a selective serotonin reuptake inhibitor (SSRI) is likely to benefit a patient.
January 24, 2020
An interactive voice application’s assessment of patient well-being through analysis of their speech was highly comparable with physicians’ tracking of patient well-being, according to a study published online in PLOS One.
January 21, 2020
Resting-state electroencephalographic (EEG) data may help in predicting the outcome of escitalopram treatment in patients with major depressive disorder (MDD), suggests a study published online in JAMA Network Open.
Back to Top